Cargando…
WIP1 promotes cancer stem cell properties by inhibiting p38 MAPK in NSCLC
Cancer stem cells (CSCs) are a small population of stem cell-like cancer cells that can initiate tumors in vivo, and are the major source of cancer initiation, relapse, and drug resistance. We previously reported that the p38 MAPK, through its downstream effectors MK2 and HSP27, suppressed CSC prope...
Autores principales: | Deng, Kaiyuan, Liu, Liang, Tan, Xiaoming, Zhang, Zhen, Li, Jianjun, Ou, Yang, Wang, Xin, Yang, Shuang, Xiang, Rong, Sun, Peiqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156655/ https://www.ncbi.nlm.nih.gov/pubmed/32296033 http://dx.doi.org/10.1038/s41392-020-0126-x |
Ejemplares similares
-
Clinical significance of Wip1 overexpression and its association with the p38MAPK/p53/p16 pathway in NSCLC
por: Yang, Shize, et al.
Publicado: (2017) -
Her2 promotes early dissemination of breast cancer by suppressing the p38-MK2-Hsp27 pathway that is targetable by Wip1 inhibition
por: Wang, Juan, et al.
Publicado: (2020) -
Wip1 regulates SKOV3 cell apoptosis through the p38 MAPK signaling pathway
por: Feng, Yanping, et al.
Publicado: (2017) -
Knockdown of Wip1 Enhances Sensitivity to Radiation in HeLa Cells Through Activation of p38 MAPK
por: Wang, Hong-yong, et al.
Publicado: (2015) -
LZAP Inhibits p38 MAPK (p38) Phosphorylation and Activity by Facilitating p38 Association with the Wild-Type p53 Induced Phosphatase 1 (WIP1)
por: An, Hanbing, et al.
Publicado: (2011)